|
Status |
Public on Mar 31, 2013 |
Title |
Upregulation of ERBB3 by FOXD3, an adaptive response to RAF and MEK inhibitors |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
To understand the transcriptional impact of FOXD3 in melanoma cells, we utilized a microarray approach. We collected RNA from three unrelated mutant B-RAF melanoma cell lines (WM115, WM793, and A375) that were engineered to inducibly express FOXD3 or the control gene, β-galactosidase (LacZ), after 5 days of transgene induction. This time point was chosen based on maximal phenotypic changes previously observed. Comparison of gene signatures between the 3 cell lines produced approximately 2,600 common genes differentially regulated by FOXD3-expressing cells compared to the LacZ controls.
|
|
|
Overall design |
Three unrelated mutant B-RAF melanoma cell lines (WM115, WM793, and A375) were induced to express FOXD3 and compared against the same cell lines expressing the control gene, β-galactosidase (LacZ).
|
|
|
Contributor(s) |
Abel EV, Ertel A, Fortina P, Aplin AE |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Jan 31, 2013 |
Last update date |
Feb 22, 2018 |
Contact name |
Adam Ertel |
Organization name |
Thomas Jefferson University
|
Department |
Cancer Biology
|
Lab |
BLSB 1009
|
Street address |
233 S 10TH ST
|
City |
PHILADELPHIA |
State/province |
PA |
ZIP/Postal code |
19107 |
Country |
USA |
|
|
Platforms (1) |
GPL4133 |
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version) |
|
Samples (3) |
|
Relations |
BioProject |
PRJNA188229 |